{
  "id": "depression_criteria",
  "type": "diagnostic_criteria",
  "name": "Major Depressive Disorder - DSM-5 Criteria",
  "content": "MAJOR DEPRESSIVE DISORDER (MDD) - DSM-5:\n\nDIAGNOSTIC CRITERIA:\n≥5 symptoms during same 2-week period (at least one is depressed mood or anhedonia):\n\n1. Depressed mood most of the day, nearly every day\n2. Markedly diminished interest/pleasure in activities (anhedonia)\n3. Significant weight loss/gain or appetite change (±5% body weight)\n4. Insomnia or hypersomnia nearly every day\n5. Psychomotor agitation or retardation\n6. Fatigue or loss of energy\n7. Feelings of worthlessness or excessive/inappropriate guilt\n8. Diminished ability to think/concentrate or indecisiveness\n9. Recurrent thoughts of death, suicidal ideation, or suicide attempt\n\nREQUIRES:\n- Symptoms cause clinically significant distress or impairment\n- Not attributable to substance or medical condition\n- No history of manic/hypomanic episode\n\nSUICIDE RISK ASSESSMENT (Columbia Protocol):\n- Suicidal ideation: passive vs active\n- Suicidal intent and plan\n- Access to means\n- Prior suicide attempts\n- Protective factors\n\nSEVERITY ASSESSMENT - PHQ-9:\n- 9-item questionnaire, score 0-27\n- 0-4: Minimal, 5-9: Mild, 10-14: Moderate, 15-19: Moderately severe, 20-27: Severe\n- Question #9 assesses suicidal ideation\n\nSPECIFIERS:\n- Severity: Mild, moderate, severe\n- With anxious distress\n- With melancholic features\n- With atypical features\n- With psychotic features\n- With peripartum onset\n- With seasonal pattern\n\nTREATMENT:\n\n1. PSYCHOTHERAPY:\n   - Cognitive behavioral therapy (CBT)\n   - Interpersonal therapy (IPT)\n   - Behavioral activation\n\n2. PHARMACOTHERAPY:\n   First-line SSRIs:\n   - Sertraline, escitalopram, fluoxetine, paroxetine, citalopram\n   \n   SNRIs:\n   - Venlafaxine, duloxetine, desvenlafaxine\n   \n   Others:\n   - Bupropion (good if fatigue/low energy)\n   - Mirtazapine (good if insomnia/poor appetite)\n   \n3. COMBINATION:\n   - Psychotherapy + medication more effective than either alone for moderate-severe\n\n4. TREATMENT-RESISTANT:\n   - ECT (electroconvulsive therapy)\n   - TMS (transcranial magnetic stimulation)\n   - Ketamine/esketamine\n   - Augmentation strategies (aripiprazole, lithium, T3)\n\nDURATION:\n- Acute phase: 6-12 weeks to remission\n- Continuation: 4-9 months after remission\n- Maintenance: ≥2 years if recurrent episodes",
  "metadata": {
    "category": "psychiatric",
    "diagnosis": "depression",
    "priority": "HIGH",
    "source": "DSM-5, APA Practice Guidelines"
  }
}
